Monday, May 07, 2018 10:33:09 AM
glta
=======================
Bryan Hansen:
https://finance.yahoo.com/news/edited-transcript-zbh-earnings-conference-123747254.html
"To that end, I'd like to discuss some of the recent additions and changes I've made to the leadership team since I joined. Since I'm sitting across from Cole right now, I'm going to go ahead and start with him. We've welcomed Cole Lannum as Senior Vice President of Investor Relations, as I'm sure many of you know. In addition, Ken Tripp recently joined Zimmer Biomet from Cardinal Health and has assumed the role of Senior Vice President of Global Operations and Logistics.
I'm also pleased to announce that Rachel Ellingson, the former Head of Strategy for St. Jude, will be joining us as the Senior Vice President of Strategy.
I've also been augmenting our reporting structure to encourage a more inclusive and responsive organization that is more deeply in tune with the needs of the business.
Consequently, the following individuals now report directly to me. Aure Bruneau, who is the group President of our Spine and CMF businesses; Pedro Malha, who is the Group Division head of our Dental business; and Angela Main, our Chief Ethics and Compliance Officer."
===========================
Rachel Ellingson
www.linkedin.com/in/rachel-ellingson-0bb01133/
SVP, Strategy at Zimmer Biomet
Greater Minneapolis-St. Paul Area
More actions
Zimmer Biomet
With broad business and healthcare industry experience developed through investment banking and executive leadership roles, I successfully drive strategic and operational initiatives to deliver results. My functional leadership experience includes business development, M&A integration, investor relations, communications, public affairs, and organizational change management.
I am known for skillfully assessing business opportunities, synthesizing core strategies and mobilizing teams to execute against those strategies. I am a persuasive communicator who drives decisions and expedites action by navigating complex situations to resolution, building deep relationships and analyzing competitive and industry dynamics.
Recognized as an authentic leader, I develop high performing teams who know they can take informed risks and will have my support. Peers come to me as a sounding board across a broad array of topics in my capacity serving as the CEO’s right-hand person. I have advised executives and Boards of Directors as they contemplate major decisions including acquisitions, divestitures and raising capital.
Working with dynamic leadership teams who continuously evolve their strategy to lead in their markets, I will drive actionable plans to enhance enterprise value and competitive position.
========================================
Kenneth Tripp
www.linkedin.com/in/kenneth-tripp-71a89674/
SVP Global Operations & Logistics
Zimmer Biomet
Experienced Vice President of Operations with a demonstrated history of working in the medical device industry. Skilled in DMAIC, Operations Management, Manufacturing, Supply Chain, Operational Quality, Medical Devices, Value Stream Mapping, and Lean Management. Strong business development professional with a Master of Business Administration (MBA) focused in Organizational Leadership from Ashford University.
Recent SINT News
- SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT • GlobeNewswire Inc. • 04/29/2024 01:14:20 PM
- SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock • GlobeNewswire Inc. • 04/03/2024 01:00:00 PM
- SINTX Technologies Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 03/29/2024 08:00:00 PM
- SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock • GlobeNewswire Inc. • 03/25/2024 01:00:00 PM
- SINTX Technologies Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 03/22/2024 12:30:00 PM
- SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET • GlobeNewswire Inc. • 02/21/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 02:00:28 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:12:54 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/07/2024 09:42:32 PM
- SINTX Technologies Announces Closing of $4.0 Million Public Offering • GlobeNewswire Inc. • 02/02/2024 07:33:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 11:30:20 AM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 02/01/2024 10:14:28 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/01/2024 05:15:22 AM
- SINTX Technologies Announces Pricing of $4.0 Million Public Offering • GlobeNewswire Inc. • 01/31/2024 02:20:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 11:05:14 AM
- SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY • GlobeNewswire Inc. • 01/30/2024 09:01:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/24/2024 09:16:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 02:05:13 PM
- SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023 REVENUE UPDATE • GlobeNewswire Inc. • 01/23/2024 02:00:00 PM
- SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO • GlobeNewswire Inc. • 01/04/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 12:10:37 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/28/2023 09:44:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 03:10:10 PM
- SINTX TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS • GlobeNewswire Inc. • 11/07/2023 02:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM